DarioHealth's MyDario to Appear on The Dr. Oz Show

CAESAREA, Israel and NEW YORK, Sept. 27, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that its MyDario product is expected to appear on The Dr. Oz Show on today. Please check your local TV listings for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show

The segment features Tracy Herbert who is passionate about helping people live a healthier life. Tracy has lived with Type 1 diabetes for almost 40 years, which has shaped her thirst for knowledge in health, fitness, and wellness. On June 13, 2017, Tracy embarked on a 3,527-mile bike ride across the United States from the Golden Gate Bridge to the Brooklyn Bridge. Her journey to increase visibility and awareness for diabetes was completed on September 13, 2017.

For more information about Tracy, please visit: https://www.tracyherbert.com

Tracy Herbert said, "Physically, it was a very difficult journey, but knowing that I had great sponsors like DarioHealth in my corner kept me motivated for the entire ride. Diabetes is a major epidemic that needs greater awareness because it is affecting more and more people in our country and across the globe. DarioHealth's creative all-in-one blood glucose monitor and smartphone app solution has done a tremendous amount to help simplify diabetes management, and I look forward to collaborating with them on more projects."

Erez Raphael, Chairman and CEO of DarioHealth, commented, "We are excited about highlighting the importance of diabetes awareness with Dr. Oz and Tracy Herbert, and promoting the need for monitoring. Our goal is to give Dr. Oz's viewers and the general public a greater understanding of living with diabetes and empowering them with the technology that can help them lead more productive, healthier and happier lives."

For more information about The Dr. Oz Show, please visit: http://www.doctoroz.com

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" are intended to identify forward-looking statements. For example, when the Company describes the upcoming appearance on the Dr. Oz show, and when the possibility of future project collaborations are mentioned, it is using forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate and Media Contact 
Shmuel Herschberg  
Marketing Director  
[email protected]   
1-914-775-5548

DarioHealth Investor Relations Contact 
Hayden IR 
Stephen Hart  
[email protected]   
1-917-658-7878

SOURCE DarioHealth Corp.